Molekuláris genetikai vizsgálatok az örökletes endokrinológiai tumor szindrómák klinikai diagnosztikájában

Translated title of the contribution: Evolution of molecular genetic methods in the clinical diagnosis of hereditary endocrine tumour syndromes

Sarkadi Balázs, Grolmusz Vince Kornél, Butz Henriett, Kövesdi Annamária, Likó István, Nyir Gábor, P. Igaz, A. Patócs

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The common features of hereditary endocrine tumour syndromes or multiple endocrine neoplasias (MEN) are the association of various tumours of different endocrine organs in one patient or within the same family. Different types can be distinguished from among which type 1 and type 2 are the most common. The mode of inheritance is autosomal dominant, meaning that there is a 50% chance to inherit the pathogenic alteration. The pathogenic variants of genes responsible for MEN syndromes have also been identified in sporadic endocrine tumours and many cases initially referred to as sporadic have been later categorized as familiar based on genetic analysis. The main role of the molecular genetic analysis in these syndromes is to identify the pathogenic variant, then, after appropriate genetic counseling, to perform the genetic screening of first-degree relatives. Following molecular genetic analysis, the state-of-the-art clinical follow-up of the clinically healthy mutation carriers may decrease or even prevent the morbidity and mortality. Due to technological developments in recent years, the molecular genetic analysis of hereditary tumour syndromes has also been changed. Using next generation based sequencing methods in routine clinical diagnostics, the number of pathogenic genes in endocrine tumours has also increased. The present review focuses on the genetic background of hereditary endocrine tumour syndromes and the recently used molecular biological methods will also be presented.

Original languageHungarian
Pages (from-to)285-292
Number of pages8
JournalOrvosi Hetilap
Volume159
Issue number7
DOIs
Publication statusPublished - Feb 1 2018

Fingerprint

Molecular Biology
Multiple Endocrine Neoplasia
Neoplasms
Genetic Counseling
Genetic Testing
Genes
Morbidity
Mutation
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Molekuláris genetikai vizsgálatok az örökletes endokrinológiai tumor szindrómák klinikai diagnosztikájában. / Balázs, Sarkadi; Kornél, Grolmusz Vince; Henriett, Butz; Annamária, Kövesdi; István, Likó; Gábor, Nyir; Igaz, P.; Patócs, A.

In: Orvosi Hetilap, Vol. 159, No. 7, 01.02.2018, p. 285-292.

Research output: Contribution to journalArticle

Balázs, Sarkadi ; Kornél, Grolmusz Vince ; Henriett, Butz ; Annamária, Kövesdi ; István, Likó ; Gábor, Nyir ; Igaz, P. ; Patócs, A. / Molekuláris genetikai vizsgálatok az örökletes endokrinológiai tumor szindrómák klinikai diagnosztikájában. In: Orvosi Hetilap. 2018 ; Vol. 159, No. 7. pp. 285-292.
@article{3c72aa8d9e6349428ff8af43bd1e93f9,
title = "Molekul{\'a}ris genetikai vizsg{\'a}latok az {\"o}r{\"o}kletes endokrinol{\'o}giai tumor szindr{\'o}m{\'a}k klinikai diagnosztik{\'a}j{\'a}ban",
abstract = "The common features of hereditary endocrine tumour syndromes or multiple endocrine neoplasias (MEN) are the association of various tumours of different endocrine organs in one patient or within the same family. Different types can be distinguished from among which type 1 and type 2 are the most common. The mode of inheritance is autosomal dominant, meaning that there is a 50{\%} chance to inherit the pathogenic alteration. The pathogenic variants of genes responsible for MEN syndromes have also been identified in sporadic endocrine tumours and many cases initially referred to as sporadic have been later categorized as familiar based on genetic analysis. The main role of the molecular genetic analysis in these syndromes is to identify the pathogenic variant, then, after appropriate genetic counseling, to perform the genetic screening of first-degree relatives. Following molecular genetic analysis, the state-of-the-art clinical follow-up of the clinically healthy mutation carriers may decrease or even prevent the morbidity and mortality. Due to technological developments in recent years, the molecular genetic analysis of hereditary tumour syndromes has also been changed. Using next generation based sequencing methods in routine clinical diagnostics, the number of pathogenic genes in endocrine tumours has also increased. The present review focuses on the genetic background of hereditary endocrine tumour syndromes and the recently used molecular biological methods will also be presented.",
keywords = "Hereditary endocrine tumour syndromes, Mutation, Parathyroid gland, Phaeochromocytoma, Sequencing",
author = "Sarkadi Bal{\'a}zs and Korn{\'e}l, {Grolmusz Vince} and Butz Henriett and K{\"o}vesdi Annam{\'a}ria and Lik{\'o} Istv{\'a}n and Nyir G{\'a}bor and P. Igaz and A. Pat{\'o}cs",
year = "2018",
month = "2",
day = "1",
doi = "10.1556/650.2018.31036",
language = "Hungarian",
volume = "159",
pages = "285--292",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "7",

}

TY - JOUR

T1 - Molekuláris genetikai vizsgálatok az örökletes endokrinológiai tumor szindrómák klinikai diagnosztikájában

AU - Balázs, Sarkadi

AU - Kornél, Grolmusz Vince

AU - Henriett, Butz

AU - Annamária, Kövesdi

AU - István, Likó

AU - Gábor, Nyir

AU - Igaz, P.

AU - Patócs, A.

PY - 2018/2/1

Y1 - 2018/2/1

N2 - The common features of hereditary endocrine tumour syndromes or multiple endocrine neoplasias (MEN) are the association of various tumours of different endocrine organs in one patient or within the same family. Different types can be distinguished from among which type 1 and type 2 are the most common. The mode of inheritance is autosomal dominant, meaning that there is a 50% chance to inherit the pathogenic alteration. The pathogenic variants of genes responsible for MEN syndromes have also been identified in sporadic endocrine tumours and many cases initially referred to as sporadic have been later categorized as familiar based on genetic analysis. The main role of the molecular genetic analysis in these syndromes is to identify the pathogenic variant, then, after appropriate genetic counseling, to perform the genetic screening of first-degree relatives. Following molecular genetic analysis, the state-of-the-art clinical follow-up of the clinically healthy mutation carriers may decrease or even prevent the morbidity and mortality. Due to technological developments in recent years, the molecular genetic analysis of hereditary tumour syndromes has also been changed. Using next generation based sequencing methods in routine clinical diagnostics, the number of pathogenic genes in endocrine tumours has also increased. The present review focuses on the genetic background of hereditary endocrine tumour syndromes and the recently used molecular biological methods will also be presented.

AB - The common features of hereditary endocrine tumour syndromes or multiple endocrine neoplasias (MEN) are the association of various tumours of different endocrine organs in one patient or within the same family. Different types can be distinguished from among which type 1 and type 2 are the most common. The mode of inheritance is autosomal dominant, meaning that there is a 50% chance to inherit the pathogenic alteration. The pathogenic variants of genes responsible for MEN syndromes have also been identified in sporadic endocrine tumours and many cases initially referred to as sporadic have been later categorized as familiar based on genetic analysis. The main role of the molecular genetic analysis in these syndromes is to identify the pathogenic variant, then, after appropriate genetic counseling, to perform the genetic screening of first-degree relatives. Following molecular genetic analysis, the state-of-the-art clinical follow-up of the clinically healthy mutation carriers may decrease or even prevent the morbidity and mortality. Due to technological developments in recent years, the molecular genetic analysis of hereditary tumour syndromes has also been changed. Using next generation based sequencing methods in routine clinical diagnostics, the number of pathogenic genes in endocrine tumours has also increased. The present review focuses on the genetic background of hereditary endocrine tumour syndromes and the recently used molecular biological methods will also be presented.

KW - Hereditary endocrine tumour syndromes

KW - Mutation

KW - Parathyroid gland

KW - Phaeochromocytoma

KW - Sequencing

UR - http://www.scopus.com/inward/record.url?scp=85041942837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041942837&partnerID=8YFLogxK

U2 - 10.1556/650.2018.31036

DO - 10.1556/650.2018.31036

M3 - Article

C2 - 29429353

AN - SCOPUS:85041942837

VL - 159

SP - 285

EP - 292

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 7

ER -